These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1620192)

  • 1. Subject recruitment and retention for longitudinal research: practical considerations for a nonintervention model.
    Streissguth AP; Guinta CT
    NIDA Res Monogr; 1992; 117():137-54. PubMed ID: 1620192
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussion: subject selection, recruitment, and retention in longitudinal studies involving perinatal substance abuse and human immunodeficiency virus infection.
    Bandstra ES
    NIDA Res Monogr; 1992; 117():183-93. PubMed ID: 1620196
    [No Abstract]   [Full Text] [Related]  

  • 3. Who is it going to be? Subject selection issues in prenatal drug exposure research.
    Fried PA
    NIDA Res Monogr; 1992; 117():121-36. PubMed ID: 1620191
    [No Abstract]   [Full Text] [Related]  

  • 4. Methodological issues in prevention research on drug use and pregnancy.
    Gilchrist LD; Gillmore MR
    NIDA Res Monogr; 1992; 117():1-17. PubMed ID: 1620189
    [No Abstract]   [Full Text] [Related]  

  • 5. Discussion: measurement issues in the study of effects of substance abuse in pregnancy.
    Coles CD
    NIDA Res Monogr; 1992; 117():248-58. PubMed ID: 1620200
    [No Abstract]   [Full Text] [Related]  

  • 6. Perinatal substance abuse and AIDS: subject selection, recruitment, and retention.
    Rich KC
    NIDA Res Monogr; 1992; 117():166-82. PubMed ID: 1620194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discussion: dilemmas in research in perinatal addiction--intervention issues.
    Finnegan LP
    NIDA Res Monogr; 1992; 117():344-8. PubMed ID: 1620206
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program.
    Kaltenbach KA; Finnegan LP
    NIDA Res Monogr; 1992; 117():259-70. PubMed ID: 1620201
    [No Abstract]   [Full Text] [Related]  

  • 9. Methodological issues in obtaining and managing substance abuse information from prenatal patients.
    Sokol RJ; Ager JW; Martier SS
    NIDA Res Monogr; 1992; 117():80-97. PubMed ID: 1620212
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction to the Perinatal-20 treatment research demonstration program.
    Rahdert ER
    NIDA Res Monogr; 1996; 166():1-5. PubMed ID: 8818161
    [No Abstract]   [Full Text] [Related]  

  • 11. How the environment affects research on prenatal drug exposure: the laboratory and the community.
    Coles CD
    NIDA Res Monogr; 1992; 117():271-92. PubMed ID: 1620202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discussion: research environment and use of multicenter studies in perinatal substance abuse research.
    Rich KC
    NIDA Res Monogr; 1992; 117():293-304. PubMed ID: 1620203
    [No Abstract]   [Full Text] [Related]  

  • 13. Measures of pregnant, drug-abusing women for treatment research.
    Selden AM
    NIDA Res Monogr; 1992; 117():194-211. PubMed ID: 1620197
    [No Abstract]   [Full Text] [Related]  

  • 14. Mandatory reporting of child abuse and research on the effects of prenatal drug exposure.
    Besharov DJ
    NIDA Res Monogr; 1992; 117():366-84. PubMed ID: 1620208
    [No Abstract]   [Full Text] [Related]  

  • 15. Recruitment and retention of adolescent women in drug treatment research.
    Palinkas LA; Atkins CJ; Noel P; Miller C
    NIDA Res Monogr; 1996; 166():87-109. PubMed ID: 8818167
    [No Abstract]   [Full Text] [Related]  

  • 16. Alcohol- and drug-dependent pregnant women: laws and public policies that promote and inhibit research and the delivery of services.
    Weber EM
    NIDA Res Monogr; 1992; 117():349-65. PubMed ID: 1620207
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis and use of qualitative data.
    Sidani S; Sechrest L
    NIDA Res Monogr; 1996; 166():292-309. PubMed ID: 8818179
    [No Abstract]   [Full Text] [Related]  

  • 18. Discussion: effect of legal stipulations on the conduct of treatment and prevention research.
    Howard J
    NIDA Res Monogr; 1992; 117():385-93. PubMed ID: 1620209
    [No Abstract]   [Full Text] [Related]  

  • 19. Subject recruitment and retention issues in longitudinal research involving substance-abusing families: a clinical services context.
    Howard J
    NIDA Res Monogr; 1992; 117():155-65. PubMed ID: 1620193
    [No Abstract]   [Full Text] [Related]  

  • 20. Issues in subject recruitment and retention with pregnant and parenting substance-abusing women.
    Howard J; Beckwith L
    NIDA Res Monogr; 1996; 166():68-86. PubMed ID: 8818166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.